Showing 5361-5370 of 20465 results for "".
- Oculis to Showcase Advancements in Ophthalmic Pipeline at Eyecelerator and AAO Annual Meetinghttps://reachmd.com/news/oculis-to-showcase-advancements-in-ophthalmic-pipeline-at-eyecelerator-and-aao-annual-meeting/2483994/Oculis Holding AG has announced that its late-stage ophthalmic pipeline will be in the spotlight at both Eyec
- PLADUOpro Plasma System Debuts in North Americahttps://reachmd.com/news/pladuopro-plasma-system-debuts-in-north-america/2483995/Aesthetic Management Partners (AMP) announced the North American launch of PLADUOpro, a dual-gas plasma device designed to support noninvasive skin resurfacing and regeneration. The device, which integrates both argon and nitro
- New National Roadmap Outlines EHR-Based Strategy to Boost Lung Cancer Screening Uptakehttps://reachmd.com/news/new-national-roadmap-outlines-ehr-based-strategy-to-boost-lung-cancer-screening-uptake/2483991/Fewer than 1 in 5 eligible U.S. patients receive guideline-recommended low-dose CT (LDCT) screening. As a result, a recent implementation report provides a bundled, system-level roadmap to raise uptake and speed diagnosis. Prog
- Zasocitinib Demonstrates Efficacy and Safety in Phase 2b Psoriatic Arthritis Trialhttps://reachmd.com/news/zasocitinib-demonstrates-efficacy-and-safety-in-phase-2b-psoriatic-arthritis-trial/2483975/Zasocitinib (TAK-279), an investigational oral tyrosine kinase 2 (TYK2) inhibitor, demonstrated improvements in joint and skin outcomes among adults with active psoriatic arthritis (PsA) in a randomized, phase
- Fertility After Uterine Artery Embolization: Clinical Takeaways for Procedure Selection and Counselinghttps://reachmd.com/news/fertility-after-uterine-artery-embolization-clinical-takeaways-for-procedure-selection-and-counseling/2483985/A recent analysis reports fertility and pregnancy outcomes after uterine artery embolization and addresses fertility counseling and procedure selection for interventional rad
- FDA Clears First Blood Test for Primary Care Use to Help Rule Out Alzheimer’shttps://reachmd.com/news/fda-clears-first-blood-test-for-primary-care-use-to-help-rule-out-alzheimers/2483971/In a landmark development that could shift how Alzheimer’s disease is assessed in its earliest stages, the U.S. Food and Drug Administration has
- PSICHE Trial Shows Promise for PSMA-PET–Guided Management of Biochemical Recurrence After Prostatectomyhttps://reachmd.com/news/psiche-trial-shows-promise-for-psma-petguided-management-of-biochemical-recurrence-after-prostatectomy/2483961/In the PSICHE prospective, multicenter trial (NCT 05022914), researchers evaluated whether tailoring salvage therapy based on ^68Ga‑PSMA PET imaging might improve outcomes in men with bioche
- Loneliness May Be a Hidden Risk Factor in Cancer Survival, New Review Findshttps://reachmd.com/news/loneliness-may-be-a-hidden-risk-factor-in-cancer-survival-new-review-finds/2483968/A growing body of research has long hinted at the consequences of loneliness on physical health. Now, a comprehensive systematic review and meta-analysis sheds new light on how loneliness and social isolation may significantly influence mortality risk among patients with cancer—underscoring an of
- First U.S. Enrollee in Nexsphere-F RESORB Pivotal Trial: What Sports Medicine Clinicians Should Knowhttps://reachmd.com/news/first-us-enrollee-in-nexsphere-f-resorb-pivotal-trial-what-sports-medicine-clinicians-should-know/2483950/The RESORB pivotal trial has enrolled its first U.S. patient, testing Nexsphere-F as a minimally invasive genicular artery embolization option for symptomatic knee osteoarthritis. According to
- Nexsphere‑F FDA Pivotal Trial Startshttps://reachmd.com/news/nexspheref-fda-pivotal-trial-starts/2483954/NEXTBIOMEDICAL has enrolled the first patient in the RESORB U.S. FDA pivotal trial for Nexsphere‑F, marking the operational start of a U.S. regulatory pathway. That regulatory milestone could change referral and treatment options for patients with refractory knee osteoarthritis pain by init